Skip to main content
Google Tag Manager
P&T COMMUNITY
Register
Sign in
Search form
Search
Home
News
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Highlights
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
JAKAFI®
ruxolitinib (tablets)
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
You are here
Home
News by month %2 2014
News by month February 2014
PTCommunity News February 2014
Report: Newer Diabetes Drugs Cost More, But May Not Work Better
Promacta (Eltrombopag) Submitted to FDA for Treatment of Severe Aplastic Anemia
Self-Administration of Flu Vaccine With Patch May be Feasible, Study Suggests
Study: Stem-Cell Injections Reduce Low Back Pain
Gallup Survey: U.S. Obesity Rate Climbs to 27% in 2013
Postsurgery Painkiller Exparel (Bupivacaine) Effective in Late-Stage Trial
New CDC Data Show Decline in Obesity Among Young Children
Report: Vascular Disease Affecting Women 'Poorly Understood' by Health Care Providers
Task Force Finds Insufficient Evidence on Whether Multivitamins Prevent Cardiovascular Disease and Cancer
Pirfenidone Delays Progression of Pulmonary Fibrosis in Late-Stage Study
Once-Weekly Dulaglutide Non-Inferior to Liraglutide in Phase III Diabetes Trial
FDA Will Review Eylea (Aflibercept) for Treatment of Macular Edema Following Retinal Vein Occlusion
FDA Approves Kalydeco (Ivacaftor) for Use in Eight Additional Mutations That Cause Cystic Fibrosis
Prevnar 13 Prevents Community-Acquired Pneumonia in Older Adults
New Phase III Study Evaluates Masitinib in Prostate Cancer
FDA Agrees to Review 9-Valent HPV Vaccine
Apixaban (Eliquis) Superior to Warfarin in Phase III Trial
Proposed Asthma Inhaler Puts Patients at Risk, Group Says
Cell Therapy Eradicates Cancer in Clinical Study
Report: Fluoride Dangerous to Childrens’ Brains?
Huntington’s Disease Drug Shows Promise in Phase II/III Trial
FDA Grants ‘Fast Track’ Designation to Extended-Release Morphine and Oxycodone
Positive Mid-Stage Results Reported for Oral Antifungal Compound
Heart Disease, Stroke-Risk Estimator App Available for Health Care Professionals
FDA Approves Northera (Droxidopa) for Patients With Neurogenic Orthostatic Hypotension
Ramucirumab Meets Primary Endpoints in Phase III Lung Cancer Trial
FDA Grants Priority Review to Intravenous Antibiotic Oritavancin
FDA Approves Vimizim (Elosulfase Alfa) to Treat Rare Congenital Enzyme Disorder
HIV Drug Reverses Effects of Virus That Causes Cervical Cancer
Task Force Issues Draft Recommendation Statement on Screening for Carotid Artery Stenosis
Illegal Drug Sellers Nabbed for Smuggling Bogus Cancer Drugs Into U.S.
New Blood Test Identifies Individuals at Risk of Heart Attack
FDA Grants Full Approval to Synribo (Omacetaxine Mepesuccinate) for CML
Report: African-Americans, Hispanics, Older Americans Not Benefiting Equally From Improvements in Colon Cancer Treatment
FDA Rejects Expanded Indications for Anticoagulant Drug Xarelto (Rivaroxiban)
FDA Rejects Depot Bupivacaine (Posidur) for Postoperative Pain Relief
Study: Metal Implants May Reduce Chemotherapy Side Effects
Pregabalin Effectively Treats Restless Leg Syndrome
Common Infections May Increase Risk of Memory Decline
FDA Panel Says Data Do Not Support Lower Cardiac Risk of Naproxen
FDA Expands Ibrutinib (Imbruvica) Label to Include Chronic Lymphocytic Leukemia
New Drug Application Filed for Ledipasvir/Sofosbuvir Combo Tablet for Hepatitis C
FDA Asks for More Trials of Female Libido Treatment
Immune Signature Predicts Poor Outcome in Flu Patients
AMA Supports Medicare Reforms
Treatment for Anxious Depression Fails Mid-Stage Trial
Experts Address Threat From ‘Superbugs’
Positive Long-Term Results Reported for Aflibercept (Eylea) in Patients With Diabetic Macular Edema
Smoking Linked With Increased Risk of Most Common Type of Breast Cancer in Young Women
FDA Committee Issues Mixed Opinions on Blood Clot Drug Cangrelor
Vyvanse (Lisdexamfetamine Dimesylate) Fails Phase III Studies in Adults With Major Depressive Disorder
New Guidelines for Reducing Stroke Risks in Women
Lawmakers Want to Reward Medicare Docs for Quality
Study: Yogurt Consumption Reduces Risk of Type 2 Diabetes
New Risk Factor Found for Schizophrenia
New Analysis of Endometriosis Could Help Diagnosis, Treatment
Positive Results Reported for Golimumab (Simponi) in Patients With Ulcerative Colitis
FDA Grants Fast Track Designation to Huntington's Disease Treatment
Amgen and Merck Collaborate on Combo Treatment for Advanced Melanoma
EHRs Hold Promise of Improved Health Care
Report: Fewer Than Half of Women Attend Recommended Doctor Visits After Childbirth
EMA401 Reduces Pain of Postherpetic Neuralgia in Mid-Stage Trial
Simple At-Home Stool Tests Detect Most Colon Cancers
Positive Phase III Data Reported for IBS Drug Eluxadoline
Report: Thousands of Unvaccinated Adults Die From Preventable Diseases
FDA Rejects Oral Film for Acute Migraines
Revised Label for Fosamprenavir Indicates That Simultaneous Administration With Esomeprazole Does Not Lower Levels
Proof-of-Concept Phase 2 Trial of DDP225 for Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome Initiated
